| Baselinea | Week 1 | Week 2 | Week 6 | Week 12 | Week 24 |
---|---|---|---|---|---|---|
Mirtazapine | n = 20 | n = 17 | n = 15 | n = 14 | n = 9 | n = 8 |
Non-use, n (%) | Â | 8 (47.1) | 7 (46.7) | 11 (78.6) | 8 (88.9) | 7 (87.5) |
1–6 days per week, n (%) |  | 5 (29.4) | 4 (26.7) | 1 (7.1) | 0 (0.0) | 0 (0.0) |
Every day, n (%) | Â | 4 (23.5) | 4 (26.7) | 2 (14.3) | 1 (11.1) | 1 (12.5) |
SSRIs | n = 45 | n = 43 | n = 42 | n = 33 | n = 28 | n = 22 |
Non-use, n (%) | Â | 12 (27.9) | 14 (33.3) | 6 (18.2) | 4 (14.3) | 4 (18.2) |
1–6 days per week, n (%) |  | 15 (34.9) | 8 (19.0) | 12 (36.4) | 9 (32.1) | 4 (18.2) |
Every day, n (%) | Â | 16 (37.2) | 20 (47.6) | 15 (45.5) | 15 (53.6) | 14 (63.6) |
Sertraline | n = 28 | n = 26 | n = 26 | n = 22 | n = 19 | n = 15 |
Non-use, n (%) | Â | 7 (26.9) | 9 (34.6) | 5 (22.7) | 3 (15.8) | 3 (20.0) |
1–6 days per week, n (%) |  | 8 (30.8) | 4 (15.4) | 7 (31.8) | 5 (26.3) | 2 (13.3) |
Every day, n (%) | Â | 11 (42.3) | 13 (50.0) | 10 (45.5) | 11 (57.9) | 10 (66.7) |
Paroxetine | n = 17 | n = 17 | n = 16 | n = 11 | n = 9 | n = 7 |
Non-use, n (%) | Â | 5 (29.4) | 5 (31.3) | 1 (9.1) | 1 (11.1) | 1 (14.3) |
1–6 day per week, n (%) |  | 7 (41.2) | 4 (25.0) | 5 (45.5) | 4 (44.4) | 2 (28.6) |
Every day, n (%) | Â | 5 (29.4) | 7 (43.8) | 5 (45.5) | 4 (44.4) | 4 (57.1) |